Database: Belgian Cancer Registry (Belgium): Difference between revisions

From Beacon
(Created page with "{{#subobject:Belgian Cancer Registry |dct:title=Belgian Cancer Registry |datatype=registry }} '''Sponsor, manager or home institution:''' Belgian Cancer Registry. '''Primary purpose:''' Population-based cancer registry collecting and processing data from patients in Belgium, monitoring cancer statistics and making data accessible. '''Type of information:''' Information collected on cancer diagnoses at patient level. '''Available type of information:''' Incidence; C...")
 
No edit summary
Line 1: Line 1:
{{#subobject:Belgian Cancer Registry
'''Sponsor, manager or home institution:''' [[dataOwner::Belgian Cancer Registry]].
|dct:title=Belgian Cancer Registry
|datatype=registry
}}
 
'''Sponsor, manager or home institution:''' Belgian Cancer Registry.


'''Primary purpose:''' Population-based cancer registry collecting and processing data from patients in Belgium, monitoring cancer statistics and making data accessible.
'''Primary purpose:''' Population-based cancer registry collecting and processing data from patients in Belgium, monitoring cancer statistics and making data accessible.
Line 10: Line 5:
'''Type of information:''' Information collected on cancer diagnoses at patient level.
'''Type of information:''' Information collected on cancer diagnoses at patient level.


'''Available type of information:''' Incidence; Count, crude rate per 100,000 persons per year; European Standardized Rate (ESR) per 100,000 persons per year; World Standardized Rate (WSR); Revised European Standardized Rate (RESR); Type of cancer; Gender; Age; Region; Year; Prevalence; Survival: observed survival and relative survival; Age at time of diagnosis; Stage at time of diagnosis. [https://kankerregister.org/default.aspx?PageId=642].
'''Available type of information:''' [[availableVariable::cancer incidence]]; European Standardized Rate (ESR) per 100,000 persons per year; World Standardized Rate (WSR); Revised European Standardized Rate (RESR); [[availableVariable::type of cancer]]; [[availableVariable::sex]]; [[availableVariable::age]]; [[availableVariable::place of residence]]; [[availableVariable::year]]; [[availableVariable::cancer prevalence]]; [[availableVariable::cancer survival]]: observed survival and relative survival; [[availableVariable::tumor staging]]. [https://kankerregister.org/default.aspx?PageId=642].


'''Source of Information:''' Healthcare facilities that have oncology care programs (including pediatric hemato-oncology) and provide services for pathological anatomy are required by law to collaborate with cancer registration.
'''Source of Information:''' Healthcare facilities that have oncology care programs (including pediatric hemato-oncology) and provide services for pathological anatomy are required by law to collaborate with cancer registration.


'''Data level:''' Patient level.
'''Data level:''' [[dataLevel::patient level]].


'''Available data level:''' National and regional level.
'''Available data level:''' [[availableDataLevel::national level]] and [[availableDataLevel::regional level]].


'''Number of Records:''' All new diagnoses in Belgium of malignant neoplasms, in situ neoplasms/high grade dysplasia, borderline tumours of the central nervous system, ovary and urinary system and benign tumours of the central nervous system.
'''Number of Records:''' All new diagnoses in Belgium of malignant neoplasms, in situ neoplasms/high grade dysplasia, borderline tumours of the central nervous system, ovary and urinary system and benign tumours of the central nervous system.


'''Date Range:''' From 2004 onwards on a national level.
'''Date Range:''' [[dataStart::2004]] [[dataEnd::onwards]] on a national level.


'''Cancer Areas of Interest:''' All new diagnoses of malignant neoplasms, in situ neoplasms/tumours with high grade dysplasia, borderline tumours of the central nervous system, ovary and urinary system and benign tumours of the central nervous system.
'''Cancer Areas of Interest:''' All new diagnoses of malignant neoplasms, in situ neoplasms/tumours with high grade dysplasia, borderline tumours of the central nervous system, ovary and urinary system and benign tumours of the central nervous system.


'''Data access:''' Partially publicly available [https://kankerregister.org/default.aspx?PageId=642]. Instructions to request data for restricted content [https://kankerregister.org/Requesting%20specific%20data].
'''Data access:''' [[dataAvailability::partially publicly available]] [https://kankerregister.org/default.aspx?PageId=642]. Instructions to request data for restricted content [[hasDataAccessInstructions::[https://kankerregister.org/Requesting%20specific%20data]]].


'''Contact information:''' Information [https://kankerregister.org/default.aspx?PageId=614].
'''Contact information:''' Information [https://kankerregister.org/default.aspx?PageId=614].

Revision as of 23:50, 18 November 2023

Sponsor, manager or home institution: Belgian Cancer Registry.

Primary purpose: Population-based cancer registry collecting and processing data from patients in Belgium, monitoring cancer statistics and making data accessible.

Type of information: Information collected on cancer diagnoses at patient level.

Available type of information: cancer incidence; European Standardized Rate (ESR) per 100,000 persons per year; World Standardized Rate (WSR); Revised European Standardized Rate (RESR); type of cancer; sex; age; place of residence; year; cancer prevalence; cancer survival: observed survival and relative survival; tumor staging. [1].

Source of Information: Healthcare facilities that have oncology care programs (including pediatric hemato-oncology) and provide services for pathological anatomy are required by law to collaborate with cancer registration.

Data level: patient level.

Available data level: national level and regional level.

Number of Records: All new diagnoses in Belgium of malignant neoplasms, in situ neoplasms/high grade dysplasia, borderline tumours of the central nervous system, ovary and urinary system and benign tumours of the central nervous system.

Date Range: 2004 onwards on a national level.

Cancer Areas of Interest: All new diagnoses of malignant neoplasms, in situ neoplasms/tumours with high grade dysplasia, borderline tumours of the central nervous system, ovary and urinary system and benign tumours of the central nervous system.

Data access: partially publicly available [2]. Instructions to request data for restricted content [3].

Contact information: Information [4].